Fahad Fayyaz Butt
Resident R1
6 year school going boy presented with Chronic
diarrhea for 6 months associated with abdominal pain,
Progressive weight loss and reduced appetite.
• Continuous, 4-5x a day , with
bleeding and mucusDiarrhea
•Diffuse , Dull aching
Abdominal
pain
Past Medical History
Anal fistulas since 2 years- taking medical therpay
1-1.5 years diarrhea on/off
Took antibiotics multiple times but no effective
improvement
Family History
One Sister have psoriasis
Developmental
History
Normal development ,4th
grader
Vaccination History
Completed
Nutritional History
Eats healthy normal diet,
but reduced appetite since
1-1.5 years
Physical examination
• Wasted, lethargicLook
• presentPallor
• absentLymph nodes
• present ( MILD)Clubbing
• absentCyanosis
• DehydratedHydration
Physical examination
CVS
Normal Heart
examination
CNS
No CNS Examination
CHEST
Normal Chest
examination
ENT
Normal ENT examination
ABDOMEN
Diffuse tenderness, no distention, no masses
palpable, no organomegaly, bowel sounds
present. Anal fistulas and fissures are present
Initial Investigations
LABS Results
WBC 11 x 10^3 U/L
mainly neutrophils
HgB 10 g /dl ( LOW)
MCV 70 fl ( LOW)
RDW 16% ( Increased)
PLT 500 x 10^3 U/L
PT and PTT normal
LFT normal
CRP Raised
ESR Raised
Mucus: present
RBCs: 10-20 /HPF
Pus cells: Numerous
OVA and Parasites: not seen
Rota and adeno virus : negative
Stool for reducing substances: negative
Culture: Normal
C. Diff toxin : normal
Fecal Calprotectin and Lactoferrin: Raised
Stool Routine and culture
• No blood in stool
• Positive for Anti-gliadin antibody IgACeliac disease
• ova and parasites seen in series of stool examinations
• No blood in stool
Giardiasis
• History of exposureG.I. T.B.
• Reducing substances should be positive in stool
• Hydrogen Breath test: positive
Lactose
Intolerance
• Recurrent URTI and LRTI
• Sweat chloride should be positive
Cystic Fibrosis
Differential diagnosis
Inflammatory Bowel
disease:
•Mild erythema distal
esophagus
Esophagus
•Patchy erythema ,mainly
antrum
Stomach
•Patchy erythema and
edema
Colon
Esophago-
duodenoscopy
Colonoscopy
Endoscopic findings
Diagnosis: Crohn’s Disease
Inflammatory Bowel Disease
Crohn’s
Disease
Ulcerative
Colitis
Ulcerative ColitisCrohn’s Disease
• UnknownCause
• Most common in Adolescents
Age
group
• Family History
• Mutations: Turner, Glycogen
storage Diseases
Risk
Factors
Clinical Presentation
72
56
22
5862
74
84
31
0
20
40
60
80
100
abdominal
pain
diarrhea bleeding weight loss
crohns disease ulcerative colitis
74
35
20 20 18
0
20
40
60
80
100
Anemia Arthritis Erythema
Nodosum
Stomatitis Scleritis &
Uveitis
Inflammatory Bowel disease
Extraintestinal Manifestation
Laboratory Crohn’s Disease Ulcerative Colitis
CBC
ESR
CRP
LFT
Fecal Calprotectin
or Lactoferrin
P-ANCA
ASCA
Negative
Positive
Investigations
↓↓ Hemoglobin ↑↑ Platelets
↑ or normal
↑ or normal
↓ Albumin
Positive
Positive
Negative
Crohn’s
Disease
Ulcerative
Colitis
Esopahgo-
duodenoscopy
edema,
erythema, friability,
granulation
• StricturesColonoscopy
Colonoscopy
edema,
erythema, friability,
granulation
• Pseudopolyps
Macroscopic appearance
Cobble stoning
In CROHN’S
Pseudopolyps In
Ulcerative Colitis
Microscopic appearance
0
20
40
60
80
100
Crypts
distortion
crypts abscess Granuloma
Crohns Disease Ulcerative colitis
Steatorrhea
Renal Stones
Growth Retardation
Sclerosing Cholangitis
Colon Cancer
Complications
• Crohn’s disease = Biliary system or Ileum
• Ulcerative Colitis = Biliary system
• Excessive Oxalate absorption
• Reduced appetite and/or decreased
absorption
• Fibrosis of intra and extra hepatic bile ducts
• Long term inflammation and damage, >10
years
Crohn’s Complications
Fistula
Strictures
Perianal
Abscess
Enteroenteral
Enterovesical
Entervaginal
Strictures
Constipation
Mild Distention
Abdominal pain
Ulcerative Colitis Complications
Toxic Megacolon
Severe Abdominal
pain
Distention
Fever
Medical Management
Diet Management
Flares
Small several Meals
Low Fiber
Low Fat
Simple carbohydrate
Protein rich
Modulen Milk
Description:
Modulen® IBD is a whole
protein powdered formulation.
It is 100% casein based and
provides 25% of the fat as MCT
Induction Transition Maintenance
Drug Management
•Modulen milk
•SteroidsInduction
• 5-ASA
• Azathipurine
• 6-Mercaptopurine
Maintenance
Modulen Milk
Oral Budesonide
IV methyl Prednisolone
Induction THERAPY
NON REMITTING
SEVERE
MILD
5-ASA
Azathiopruine
6-MP
Methotrexate
Infliximab
Maintenance THERAPY
TMPT TEST
TUBERCULIN TEST
NON-RESPONSIVE
Start
Surgical Management
Indication
• Perforation
• Strictures
• Fistulas
• Perianal abscess
• Intractable Bleeding
• TOXIC MEGACOLON
Complications
• Recurrence of strictures at
site of surgery.
• Leak at site of anastomosis
Prognosis
Relapses
Retarded
Height
Osteopenia
Drug side
effects
Colon
Cancer

inflammatory bowel disease

Editor's Notes

  • #13 Both can be considered different variants of the same problem. Both are equally common among children , CD> UC
  • #14 Crohn’s Disease: Anywhere from Mouth to anus Ulcerative Colitis: involves the rectum and colon
  • #15 Cause: According to Nelson the Cause is disproportionate response of environmental factors in genetically susceptible individuals. Age group: 10- 20 years most common, in pediatric population cases come between 6-10 years, < 1% below 1 year. Risk factors: FH: one member: 7-30% , both parents : > 35% , Turner , hermansky – pudalk syndrome , Glycogen storage disease Poor associations: Living in industrialized nation, on western diet, early and frequent antibiotic usage, decreased exposure to microbes. Protective factors: Cigarette smoking in Ulcerative colitis
  • #16 Presenting Symptoms such as abdominal pain, diarrhea, bleeding and weight loss are common to both variants of IBD, although bleeding as a symptom is more common in UC but still its part of CD presentation as well.
  • #17 It is uncommon to see Extraintestinal Manifestations as presenting signs and symptoms, and is something that may develop overtime
  • #24 Management : surgery and antibiotics for perianal abscess
  • #25 Surgery: stricturoplasty
  • #27 Management : sugery
  • #29 Modulen Milk : anti-inflammatory properties, Atleast 2 week , PO or NG , only with water, no other diet necessary ; advantage over normal diet is , it doesn’t induces early satiety, less likely to induce abdominal pain, diarrhea
  • #33 5-ASA= Penatasa, asacol, rowasa TMPT test: positive we start therapy if negative we dont Methotrexate: folic acid Biological agent: adalimumab, vedolizumab,
  • #35 Relapse: unknown , even after good treatment.? NSAID ? Enteric infeections such as clostridium difficile Retarded height and osteopenia: vit d deficiency, reduced appetite, malabsorption , steroid usage Drug side effects : due to usage of immunomodulators such as AZA, 6-MP, methotrexate results in myelotoxicity hepatitis, pancreatitis then effects of steroids. Colon cancer: after 8-10 years of condition need colonoscopy after every 1-2 years , may need colectomy if severe dysplasia